KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Vertex Pharmaceuticals (VRTX) Shares Repurchased: 2018-2025

Historic Shares Repurchased for Vertex Pharmaceuticals (VRTX) over the last 7 years, with Sep 2025 value amounting to $1.1 billion.

  • Vertex Pharmaceuticals' Shares Repurchased rose 248.10% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 153.87%. This contributed to the annual value of $1.2 billion for FY2024, which is 175.28% up from last year.
  • As of Q3 2025, Vertex Pharmaceuticals' Shares Repurchased stood at $1.1 billion, which was up 173.38% from $391.8 million recorded in Q2 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Shares Repurchased peaked at $1.1 billion during Q3 2025, and registered a low of $28.3 million during Q2 2023.
  • In the last 3 years, Vertex Pharmaceuticals' Shares Repurchased had a median value of $307.7 million in 2024 and averaged $317.6 million.
  • The largest annual percentage gain for Vertex Pharmaceuticals' Shares Repurchased in the last 5 years was 1,031.80% (2024), contrasted with its biggest fall of 1.20% (2024).
  • Over the past 4 years, Vertex Pharmaceuticals' Shares Repurchased (Quarterly) stood at $368.2 million in 2021, then reached $149.5 million in 2023, then soared by 179.53% to $417.9 million in 2024, then spiked by 248.10% to $1.1 billion in 2025.
  • Its Shares Repurchased stands at $1.1 billion for Q3 2025, versus $391.8 million for Q2 2025 and $426.1 million for Q1 2025.